I agree that this site is using cookies. You can find further informations here.
X
Messina, V.
2061  results:
Search for persons X
?
1

Efficacy and safety of lusutrombopag in a real-world Italia..:

Gallo, P. ; De Vincentis, A. ; Pace-Palitti, V....
Digestive and Liver Disease.  56 (2024)  - p. S69-S70 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Verona liver day: Data of liver health from the Arena:

Sacerdoti, D. ; Paon, V. ; Ieluzzi, D....
Digestive and Liver Disease.  55 (2023)  - p. S69 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Escitalopram effects on functional connectivity of major de..:

Arnone, F. ; Mazzola, S. ; Messina, V....
Neuroscience Applied.  2 (2023)  - p. 102768 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Epidemiological, virological and clinical profile of HBsAg ..:

Coco, B. ; Tosti, M.E. ; Raimondo, G....
Digestive and Liver Disease.  54 (2022)  - p. S15-S16 , 2022
Link: https://doi.org/10.1016/..
 
?
5

The "CASERTA MODEL": Caserta HCV Free Hospital:

Messina, V. ; Petruzziello, A. ; Tripaldelli, E....
Digestive and Liver Disease.  53 (2021)  - p. S16 , 2021
Link: https://doi.org/10.1016/..
 
?
6

THE "CASERTA MODEL". AN HCV WAY OUT IN PERSONS WHO USE DRUG..:

Messina, V. ; Russo, A. ; Parente, E....
Digestive and Liver Disease.  52 (2020)  - p. e28 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Negative impact of hyperglycaemia on tocilizumab therapy in..:

Marfella, R. ; Paolisso, P. ; Sardu, C....
Diabetes & Metabolism.  46 (2020)  5 - p. 403-405 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Virological patterns of hepatitis C virus patients with fai..:

Pisaturo, M. ; Starace, M. ; Minichini, C....
International Journal of Antimicrobial Agents.  56 (2020)  3 - p. 106067 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Bioconversion of pumpkin by-products in novel supplements s..:

Genevois, C. ; Pieniazek, F. ; Messina, V...
LWT.  105 (2019)  - p. 23-29 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Daclatasvir/sofosbuvir and ribavirin 800mg flat dose is hig..:

Pellicelli, A. ; Messina, V. ; Tarquini, P....
Digestive and Liver Disease.  49 (2017)  1 - p. e64 , 2017
Link: https://doi.org/10.1016/..
 
?
11

The challenge of HCV-retreatment after DAA-failure: real-li..:

Cento, V. ; Barbaliscia, S. ; Di Maio, V.C....
Journal of Hepatology.  66 (2017)  1 - p. S744-S745 , 2017
Link: https://doi.org/10.1016/..
 
?
12

A different perspective on sofosbuvir‐ledipasvir treatment ..:

Barone, M. ; Iannone, A. ; Shahini, E....
Journal of Viral Hepatitis.  25 (2017)  1 - p. 56-62 , 2017
Link: https://doi.org/10.1111/..
 
?
13

Optimization of direct antiviral agent treatment schedule i..:

Granata, R. ; Valvano, M.R. ; Donnarumma, L....
Journal of Hepatology.  66 (2017)  1 - p. S734 , 2017
Link: https://doi.org/10.1016/..
 
?
14

Entecavir monotherapy improves renal function in patients d..:

Viganò, M. ; Grossi, G. ; Loglio, A....
Digestive and Liver Disease.  49 (2017)  1 - p. e37 , 2017
Link: https://doi.org/10.1016/..
 
?
15

The challenge of HCV-retreatment after DAA-failure: Italian..:

Cento, V. ; Barbaliscia, S. ; Di Maio, V.C....
Digestive and Liver Disease.  49 (2017)  1 - p. e8 , 2017
Link: https://doi.org/10.1016/..
 
1-15